Mantle Cell Lymphoma — Trials

Mantle Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 180
Recruiting: 93
Ph III recruiting: 6
Growth YoY: —
Industry share: 26%
Top sponsor: City of Hope Medical Center
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04662255	Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)(BRUIN-MCL-321)	active not recruiting	Phase 3	500	Loxo Oncology, Inc.INDUSTRY	24	Sep 23, 2026	clinicaltrials
NCT03267433	Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission	active not recruiting	Phase 3	689	ECOG-ACRIN Cancer Research GroupNETWORK	2